Floatz logo

Primepro™/ Primemsk™

Diabetes Complications

Thomas Advanced Medical LLCCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Diabetes Complications cohort.

Asset / SponsorPhaseRating
Exenatide
University of California, Davis
Phase 2CCC
Omnipaque
University of Colorado, Denver
Phase 1/2CCC
SODIUM P-AMINOHIPPURATE
University of Colorado, Denver
Phase 1/2CCC
Gfb-024
Goldfinch Bio, Inc.
Phase 1CC

Same molecule, other indications

Primepro™/ Primemsk™ is also rated in:

sexual disorderDormant
CCC
Indicative ·
48 / 100
View asset →
cardiovascular disorderDormant
CCC
Indicative ·
48 / 100
View asset →
integumentary system disorderDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →